JANX: Janux Therapeutics Inc

JANX新闻

• 15:16 Will Acute Care Strength Help Universal Health Offset Q1 Rising Costs?
• 15:12 Will Higher Costs & Lower Occupancy Impact HCA's Q1 Earnings?
• 14:12 Stocks Retreat on Middle East Peace Doubts
• 17:33 Will Health Benefits Weakness Drag Elevance's Q1 Earnings?
• 18:29 Janux Therapeutics Secures $35M Milestone Payment From BMY Deal
• 15:09 Truist因竞争因素下调Janux Therapeutics目标价
• 15:08 Truist cuts Janux Therapeutics stock price target on competition
• 12:09 Janux therapeutics doses first participant in JANX011 phase 1 trial
• 02:24 Vir Biotechnology Stock: The Low-Down On The Readouts Ahead (NASDAQ:VIR)
• 14:55 Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?
• 12:12 Janux Therapeutics任命William Go为新任首席医疗官
• 12:05 Janux Therapeutics appoints William Go as new chief medical officer
• 20:52 Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion (BMY)
• 12:18 JANX Enters Global Oncology Collaboration With BMY, Stock Rises
• 14:30 Janux股价在与百时美施贵宝达成合作协议后上涨
• 14:22 Janux stock rises after Bristol Myers Squibb collaboration deal
• 14:02 Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million - Janux Therapeutics (NASDAQ:JANX)